Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies.

Bonhoeffer J, Bentsi-Enchill A, Chen RT, Fisher MC, Gold MS, Hartman K, Heininger U, Hoet B, Jefferson T, Khuri-Bulos N, Kohl KS, Marcy SM, Nalin D, Pless R, Sanabria-Rojas H, Sleeman K, Wise R; Brighton Collaboration Methods Working Group.

Vaccine. 2009 Apr 6;27(16):2282-8. doi: 10.1016/j.vaccine.2008.11.036. Epub 2008 Dec 3. No abstract available.

PMID:
19056451
3.

Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M; Brighton Collaboration GBS Working Group.

Vaccine. 2011 Jan 10;29(3):599-612. doi: 10.1016/j.vaccine.2010.06.003. Epub 2010 Jun 18. Review. No abstract available.

PMID:
20600491
4.
5.

Use of vaccine surveillance data in the evaluation of safety of vaccines.

Postila V, Kilpi T.

Vaccine. 2004 May 7;22(15-16):2076-9. Review.

PMID:
15121327
6.

Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

Bonhoeffer J, Menkes J, Gold MS, de Souza-Brito G, Fisher MC, Halsey N, Vermeer P; Brighton Collaboration Seizure Working Group.

Vaccine. 2004 Jan 26;22(5-6):557-62. Review. No abstract available.

PMID:
14741144
7.

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

Rothstein E, Kohl KS, Ball L, Halperin SA, Halsey N, Hammer SJ, Heath PT, Hennig R, Kleppinger C, Labadie J, Varricchio F, Vermeer P, Walop W; Brighton Collaboration Local Reaction Working Group.

Vaccine. 2004 Jan 26;22(5-6):575-85. Review. No abstract available.

PMID:
14741147
8.

Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.

Bonhoeffer J, Gold MS, Heijbel H, Vermeer P, Blumberg D, Braun M, de Souza-Brito G, Davis RL, Halperin S, Heininger U, Khuri-Bulos N, Menkes J, Nokleby H; Brighton Collaboration HHE Working Group.

Vaccine. 2004 Jan 26;22(5-6):563-8. Review. No abstract available.

PMID:
14741145
9.

New book about vaccine safety.

Offit PA.

Pediatrics. 2008 Oct;122(4):871-2. doi: 10.1542/peds.2008-2275. Review. No abstract available.

PMID:
18829814
10.

Vaccine safety surveillance using large linked databases: opportunities, hazards and proposed guidelines.

Verstraeten T, DeStefano F, Chen RT, Miller E.

Expert Rev Vaccines. 2003 Feb;2(1):21-9. Review.

PMID:
12901594
11.

Vaccines under study: non-HIV vaccines.

Conner K, Wuu A, Maldonado V, Bartlett BL, Tyring SK.

Dermatol Ther. 2009 Mar-Apr;22(2):168-85. doi: 10.1111/j.1529-8019.2009.01229.x. Review.

PMID:
19335728
12.

The safety of vaccines.

O'Hagan DT, Rappuoli R.

Drug Discov Today. 2004 Oct 1;9(19):846-54. Review. No abstract available.

PMID:
15381137
13.

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.

Marcy SM, Kohl KS, Dagan R, Nalin D, Blum M, Jones MC, Hansen J, Labadie J, Lee L, Martin BL, O'Brien K, Rothstein E, Vermeer P; Brighton Collaboration Fever Working Group.

Vaccine. 2004 Jan 26;22(5-6):551-6. Review. No abstract available.

PMID:
14741143
14.

Statistical methods for assessing long-term analyte stability in biological matrices.

Hoffman D, Kringle R, Singer J, McDougall S.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Aug 1;877(23):2262-9. doi: 10.1016/j.jchromb.2008.08.015. Epub 2008 Aug 29. Review.

PMID:
18789775
15.

[Acceptance and safety of vaccines].

Bartz H, von Knebel-Döberitz M.

Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S71-6. doi: 10.1055/s-0029-1220213. Epub 2009 Apr 7. Review. German.

PMID:
19353475
16.

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.

Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S109-18. doi: 10.1097/INF.0b013e318199f62d. Review.

PMID:
19325447
17.

Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS.

Global Advisory Committee on Vaccine Safety (GACVS); WHO secretariat.

Expert Rev Vaccines. 2009 Jun;8(6):705-16. doi: 10.1586/erv.09.40. Review.

PMID:
19485752
18.

The problem with Dr Bob's alternative vaccine schedule.

Offit PA, Moser CA.

Pediatrics. 2009 Jan;123(1):e164-9. doi: 10.1542/peds.2008-2189. Review.

19.

Ethical aspects of the methods used to evaluate the safety of vaccines.

Spier RE.

Vaccine. 2004 May 7;22(15-16):2085-90. Review. No abstract available.

PMID:
15121329
20.

Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials.

Taddio A, Ilersich AL, Ipp M, Kikuta A, Shah V; HELPinKIDS Team.

Clin Ther. 2009;31 Suppl 2:S48-76. doi: 10.1016/j.clinthera.2009.07.024. Review.

PMID:
19781436

Supplemental Content

Support Center